As previously mentioned, SCN2A disease-causing variants may be responsible of benign (self-limiting) disorders, but in most of the cases (60–70%), they may result in neonatal-infantile DEE with drug-resistant seizures and poor neurodevelopmental outcomes [31]. The gene discussed is SCN2A; the disease is developmental and epileptic encephalopathy.